COMPARISON OF IN VITRO AND IN VIVO EFFECTS OF THYMIDINE ON L1210 LEUKEMIA IN MICEZAHARKO DS; RAMONAS LM.1982; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1982; VOL. 68; NO 5; PP. 875-880; BIBL. 24 REF.Article

PHYSIOLOGICAL PHARMACOKINETICS: AN IN VIVO APPROACH TO MEMBRANE TRANSPORTLUTZ RJ; DEDRICK RL; ZAHARKO DS et al.1980; PHARMACOL. THER.; ISSN 0163-7258; USA; DA. 1980; VOL. 11; NO 3; PP. 559-592; BIBL. 2 P.Article

DEVICE FOR CONSTANT SC INFUSION OF METHOTREXATE: PLASMA RESULTS IN MICE.PINEDO HM; ZAHARKO DS; DEDRICK RL et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 7; PP. 889-893; BIBL. 7 REF.Article

IN VITRO INHIBITORY EFFECTS OF POLYMER-LINKED METHOTREXATE DERIVATIVES ON TETRAHYDROFOLATE DEHYDROGENASE AND MURINE L5178Y CELLSWING PUN FUNG; PRZYBYLSKI M; RINGSDORF H et al.1979; J. NATION. CANCER INST.; USA; DA. 1979; VOL. 62; NO 5; PP. 1261-1264; BIBL. 16 REF.Article

RELATIVE TOXICITY OF METHOTREXATE IN SEVERAL TISSUES OF MICE BEARING LEWIS LUNG CARCINOMA = LA TOXICITE RELATIVE DU METHOTREXATE DANS PLUSIEURS TISSUS DE SOURIS PORTANT UN CARCINOME PULMONAIRE DE LEWISZAHARKO DS; DEDRICK RL; PEALE AL et al.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 189; NO 3; PP. 585-592; BIBL. 19REF.Article

PHARMACOKINETICS AND CELL POPULATION GROWTH MODELS IN CANCER CHEMOTHERAPYBISCHOFF KB; HIMMELSTEIN KJ; DEDRICK RL et al.1973; ADV. CHEM. SER.; U.S.A.; DA. 1973; NO 118; PP. 47-64; BIBL. 20REF.Article

LIPOSOMES AND LOCAL HYPERTHERMIA: SELECTIVE DELIVERY OF METHOTREXATE TO HEATED TUMORSWEINSTEIN JN; MAGIN RL; YATVIN MB et al.1979; SCIENCE; USA; DA. 1979; VOL. 204; NO 4389; PP. 188-191; BIBL. 21 REF.Article

THE RELATIVE CONTRIBUTION OF DRUG CONCENTRATION AND DURATION OF EXPOSURE TO MOUSE BONE MARROW TOXICITY DURING CONTINUOUS METHOTREXATE INFUSION.PINEDO HM; ZAHARKO DS; BULL J et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 2; PP. 445-450; BIBL. 25 REF.Article

TREATMENT OF SOLID L1210 MURINE TUMORS WITH LOCAL HYPERTHERMIA AND TEMPERATURE-SENSITIVE LIPOSOMES CONTAINING METHOTREXATEWEINSTEIN JN; MAGIN RL; CYSYK RL et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 5; PP. 1388-1395; BIBL. 40 REF.Article

PHARMACOKINETIC STUDIES DURING PHASE I TRIALS OF HIGH-DOSE THYMIDINE INFUSIONSZAHARKO DS; BOLTEN BJ; CHIUTEN D et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 12; PP. 4777-4781; BIBL. 19 REF.Article

THE REVERSAL OF METHOTREXATE CYTOTOXICITY TO MOUSE BONE MARROW CELLS BY LEUCOVORIN AND NUCLEOSIDES.PINEDO HM; ZAHARKO DS; BULL JM et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 12; PP. 4418-4424; BIBL. 44 REF.Article

CLINICAL PHASE I-II AND PHARMACOKINETIC STUDY OF HIGH-DOSE THYMIDINE GIVEN BY CONTINUOUS INTRAVENOUS INFUSIONCHIUTEN DF; WIERNICK PH; ZAHARKO DS et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 3; PP. 818-822; BIBL. 37 REF.Article

DEVICE FOR CONTROLLED DRUG RELEASE. APPLICATION TO METHOTREXATE INFUSION IN MICE = UN DISPOSITIF POUR LA LIBERATION CONTROLEE DES MEDICAMENTS. APPLICATION A LA PERFUSION DE METHOTREXATE CHEZ LES SOURISDEDRICK RL; ZAHARKO DS; LUTZ RJ et al.1974; BIOCHEM. PHARMACOL.; G.B.; DA. 1974; VOL. 23; NO 17; PP. 2457-2461; BIBL. 16REF.Article

DISTRIBUTION OF ANTICANCER AGENTS IN SPONTANEOUS ANIMAL TUMORS. I. REGIONAL BLOOD FLOW AND METHOTREXATE DISTRIBUTION IN CANINE LYMPHOSARCOMA = DISTRIBUTION DES AGENTS ANTICANCEREUX DANS LES TUMEURS ANIMALES SPONTANEES. I. CIRCULATION SANGUINE REGIONALE ET DISTRIBUTION DU METHOTREXATE DANS LE LYMPHOSARCOME DU CHIENSTRAW JA; HART MM; KLUBES P et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 52; NO 4; PP. 1327-1331; BIBL. 16REF.Article

THE KINETICS OF METHATREXATE DISTRIBUTION IN SPONTANEOUS CANINE LYMPHOSARCOMALUTZ RJ; DEDRICK RL; STRAW JA et al.1975; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1975; VOL. 3; NO 2; PP. 77-97; BIBL. 16REF.Article

TOXICOLOGIC EFFECTS OF A HIGH DOSE OF THYMIDINE IN MICEHERMAN EH; JORDAN W; ARDALAN B et al.1980; TOXICOL. APPL. PHARMACOL.; ISSN 0041-008X; USA; DA. 1980; VOL. 56; NO 3; PP. 443-446; BIBL. 15 REF.Article